Towards the Biological Understanding of CTC: Capture Technologies, Definitions and Potential to Create Metastasis

Circulating Tumor Cells (CTC) are rare cells originated from tumors that travel into the blood stream, extravasate to different organs of which only a small fraction will develop into metastasis. The presence of CTC enumerated with the CellSearch system is associated with a relative short survival a...

Full description

Bibliographic Details
Main Authors: Barradas, Ana M.C., Terstappen, Leon W.M.M.
Format: Online
Language:English
Published: MDPI 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3875957/
id pubmed-3875957
recordtype oai_dc
spelling pubmed-38759572013-12-31 Towards the Biological Understanding of CTC: Capture Technologies, Definitions and Potential to Create Metastasis Barradas, Ana M.C. Terstappen, Leon W.M.M. Review Circulating Tumor Cells (CTC) are rare cells originated from tumors that travel into the blood stream, extravasate to different organs of which only a small fraction will develop into metastasis. The presence of CTC enumerated with the CellSearch system is associated with a relative short survival and their continued presence after the first cycles of therapy indicates a futile therapy in patients with metastatic carcinomas. Detailed characterization of CTC holds the promise to enable the choice of the optimal therapy for the individual patients during the course of the disease. The phenotype, physical and biological properties are however not well understood making it difficult to assess the merit of recent technological advancements to improve upon the capture of CTC or to evaluate their metastatic potential. Here we will discuss the recent advances in the classification of CTC captured by the CellSearch system, the implications of their features and numbers. Latest capture platforms are reviewed and placed in the light of technology improvements needed to detect CTC. Physical properties, phenotype, viability and proliferative potential and means to assess their proliferation and metastatic capacity will be summarized and placed in the context of the latest CTC capture platforms. MDPI 2013-12-04 /pmc/articles/PMC3875957/ /pubmed/24305653 http://dx.doi.org/10.3390/cancers5041619 Text en © 2013 by the authors; licensee MDPI, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0/ This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Barradas, Ana M.C.
Terstappen, Leon W.M.M.
spellingShingle Barradas, Ana M.C.
Terstappen, Leon W.M.M.
Towards the Biological Understanding of CTC: Capture Technologies, Definitions and Potential to Create Metastasis
author_facet Barradas, Ana M.C.
Terstappen, Leon W.M.M.
author_sort Barradas, Ana M.C.
title Towards the Biological Understanding of CTC: Capture Technologies, Definitions and Potential to Create Metastasis
title_short Towards the Biological Understanding of CTC: Capture Technologies, Definitions and Potential to Create Metastasis
title_full Towards the Biological Understanding of CTC: Capture Technologies, Definitions and Potential to Create Metastasis
title_fullStr Towards the Biological Understanding of CTC: Capture Technologies, Definitions and Potential to Create Metastasis
title_full_unstemmed Towards the Biological Understanding of CTC: Capture Technologies, Definitions and Potential to Create Metastasis
title_sort towards the biological understanding of ctc: capture technologies, definitions and potential to create metastasis
description Circulating Tumor Cells (CTC) are rare cells originated from tumors that travel into the blood stream, extravasate to different organs of which only a small fraction will develop into metastasis. The presence of CTC enumerated with the CellSearch system is associated with a relative short survival and their continued presence after the first cycles of therapy indicates a futile therapy in patients with metastatic carcinomas. Detailed characterization of CTC holds the promise to enable the choice of the optimal therapy for the individual patients during the course of the disease. The phenotype, physical and biological properties are however not well understood making it difficult to assess the merit of recent technological advancements to improve upon the capture of CTC or to evaluate their metastatic potential. Here we will discuss the recent advances in the classification of CTC captured by the CellSearch system, the implications of their features and numbers. Latest capture platforms are reviewed and placed in the light of technology improvements needed to detect CTC. Physical properties, phenotype, viability and proliferative potential and means to assess their proliferation and metastatic capacity will be summarized and placed in the context of the latest CTC capture platforms.
publisher MDPI
publishDate 2013
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3875957/
_version_ 1612042516805189632